Children who had previously received Morbilli-(Mumps) Rubella (MMR) vaccine developed parotid swelling which was diagnosed as acute parotitis 7 days to 2 years following inoculation. Blood samples from each of the patients were tested for the following virological parameters: Mumps-virus, Parainfluenza-viruses (PIV) type 1., 2., 3., Respiratory Syncytial Virus (RSV), Epstein Barr Virus Capsid Antigen (EBVCA) IgM, IgA, IgG immunofluorescent test (IFT) and EBVCA IgM, IgG ELISA (HUMAN); Epstein Barr Virus Early Antigen (EBV EA) IgG IFT; Adenovirus, Influenza A, B Complement Fixation (CF) test. Some of the sera were examined for CMV IgM, IgG ELISA (Organon Teknika) and Human Parvovirus B19 IgM, IgG recombinant ELISA (Bender) too. Nine cases were interpreted as a clinical reaction of mumps vaccination. Beside the clinical reaction of mumps vaccination. Beside the clinical reaction of mumps vaccination, the etiological role of PIV-1, PIV-2, PIV-3 and PIV-1,2 was confirmed in four, three, one and one patients, respectively. The alonely etiological agent was the PIV-2 in four and PIV-2 and Epstein-Barr virus together were in one patients, respectively. The etiology was unknown in one patient. The results show the importance both of the broad spectrum precise serologic studies and of the skillful interpretation in the exact diagnosis of the acute parotitis to identify parotitis either as a consequence of the mumps vaccine or vaccine failure. The correct diagnosis of acute parotitis can influence the booster mumps vaccination practice too.
Download full-text PDF |
Source |
---|
Cureus
December 2024
Department of Family and Community Medicine, Arabian Gulf University, Manama, BHR.
Introduction: Mumps is a vaccine-preventable disease caused by the paramyxovirus affecting the salivary gland and may be complicated by orchitis, oophoritis, and encephalitis. This study aims to describe the epidemiology, clinical presentation, and transmission of mumps cases in the Kingdom of Bahrain between 2012 and 2022.
Methodology: A retrospective cross-sectional study was conducted using national surveillance data of confirmed mumps cases, including all age groups and both Bahraini and non-Bahraini nationals, from January 2012 to December 2022.
Dermatologie (Heidelb)
February 2025
Department of Dermatology and Allergy, Klinikum rechts der Isar, Technical University, München, Deutschland.
Background: Vaccine granulomas are a common (0.3-1%) adverse event (AE) of (accidentally) subcutaneously administered vaccines and specific immunotherapies containing aluminum conjugates. The clinical symptoms with persistent itching subcutaneous nodules, predominantly affect infants and young children on the lateral thigh.
View Article and Find Full Text PDFAn Pediatr (Engl Ed)
January 2025
Pediatrician, Barcelona, Spain.
The AEP 2025 Vaccination and Immunization Schedule recommended for children, adolescents and pregnant women residing in Spain features the following novelties: Due to the increase in measles cases and outbreaks in recent years, we recommend advancing the second dose of measles, mumps and rubella (MMR) vaccine to 2 years of age. As a consequence of the above, since many autonomous communities (ACs) use the quadrivalent vaccine for the second dose of MMR and varicella vaccines, we recommend, for all ACs, advancing the second dose of varicella vaccine to 2 years of age. Due to the very significant increase in cases of pertussis since late 2023 and especially in 2024, we recommend advancing the dose of Tdap given in adolescence to 10-12 years of age.
View Article and Find Full Text PDFInt Med Case Rep J
January 2025
Department of Dermatology and Venereology, Faculty of Medicine, Universitas Padjadjaran - Dr. Hasan Sadikin Hospital, Bandung, Indonesia.
Anogenital warts (AGW) including multiple types of human papillomavirus (HPV) are prevalent. In this context, oncogenic HPV infection leads to anogenital cancers and the lesion is more persistent. Several research on AGW therapy with measles, mumps, and rubella (MMR) vaccine injections have been successful without adverse effects.
View Article and Find Full Text PDFJAMA Ophthalmol
January 2025
Department of Cornea and Refractive Surgery, Narayana Nethralaya, Bangalore, India.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!